Analysis of Fumakilla Limited (4998)
Fumakilla Limited, with the symbol 4998, has shown some interesting trends in the past few days. Here are some key points from the data:
1. **Price Movement**: The closing prices have been fluctuating, with the latest closing price at 1241.00000. The stock has seen highs and lows, indicating some volatility in the market.
2. **Technical Indicators**:
- **RSI Indicator**: The Relative Strength Index (RSI) values have been around 60-70, suggesting the stock is neither overbought nor oversold.
- **MACD Indicator**: The Moving Average Convergence Divergence (MACD) values have been positive, indicating a bullish trend.
- **Moving Averages**: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all showing an upward trend, indicating a positive momentum.
3. **Overall Analysis**: Fumakilla Limited seems to be in a bullish phase based on the MACD indicator and moving averages. The RSI values suggest a balanced market sentiment without extreme overbought or oversold conditions.
Investors may want to keep an eye on further price movements and monitor how the technical indicators evolve to make informed decisions about Fumakilla Limited.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a particular company.
In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.44.
Moving on to stock statistics, the company has a short ratio of 1.66, with 94.31 million shares shorted out of 15.31 billion float shares. The average 10-day volume is 52.90 million shares, while the average 90-day volume is 62.82 million shares. The stock has a market capitalization of $2.91 trillion.
Valuation metrics show a PEG ratio of 26.21, forward P/E of 26.21, and trailing P/E of 29.43. The enterprise value is $2.95 trillion, with a price-to-book ratio of 39.18 and price-to-sales ratio of 7.62. The stock has an enterprise-to-EBITDA ratio of 22.75 and an enterprise-to-revenue ratio of 7.73.
The stock price summary includes a beta of 1.26, a 50-day moving average of $173.69, and a 200-day moving average of $180.79. The stock's 52-week low is $164.08, the high is $199.62, and the change over the past 52 weeks is 8.25%.
Lastly, in terms of dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of $1. The stock's ex-dividend date is May 10, 2024, with a dividend date of May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split. The 5-year average dividend yield is 0.73% and the trailing annual dividend yield is 0.51%.
Income statement 💸
Here are the revenue figures for the past four fiscal years:
1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- There was a decrease in sales from FY 2022 to FY 2023.
- Prior to that, there was an increase in sales from FY 2021 to FY 2022.
- The highest sales figure was recorded in FY 2022.
- There was a significant increase in sales from FY 2020 to FY 2021.
These trends indicate fluctuations in revenue over the past four fiscal years, with varying growth rates and performance levels.
Balance Sheet
These are balance sheets. Here are the conclusions based on the provided data:
1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,583,000,000.
2. The current assets consist mainly of cash, inventory, and receivables, with a significant portion in short-term investments.
3. Non-current assets include investments, machinery, and land improvements.
4. Total liabilities have also been increasing, with the highest value in 2023 at $290,437,000,000.
5. Current liabilities include short-term debt, accounts payable, and other current liabilities.
6. Non-current liabilities consist of long-term debt and other non-current liabilities.
7. Shareholders' equity has shown fluctuations but has generally been positive, with the highest value in 2023 at $62,146,000,000.
8. The company has been investing in leases, machinery, and investments over the years.
9. There is a significant amount of cash and cash equivalents in the current assets, indicating liquidity.
10. Accumulated depreciation is a significant factor affecting the value of non-current assets.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant variability, with large amounts being spent on common stock repurchase and debt issuance/payments.
6. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial activities show a mix of stability in operations and variability in financing and investing decisions.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates show an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. The company is projected to experience steady growth in the upcoming quarters and years, indicating a positive outlook according to analyst consensus.
Price target
The analysts' forecast for the future price of the security paper is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating a potential opportunity for growth according to the analysts' predictions.MACD of 4998